List of bibliographic references indexed by dose
Number of relevant bibliographic references: 26.
[0-20] [
0 - 20][
0 - 26][
20-25][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000129 (2017) |
Rachel H. Parkinson [Canada] ; Jacelyn M. Little [Canada] ; John R. Gray [Canada] | A sublethal dose of a neonicotinoid insecticide disrupts visual processing and collision avoidance behaviour in Locusta migratoria. |
| 000706 (2015) |
Leigh G. Parkinson [Canada] ; Ana Toro ; Hongyan Zhao ; Keddie Brown ; Scott J. Tebbutt ; David J. Granville | Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low-dose ultraviolet light irradiation. |
| 000981 (2014) |
Craig J. Hudson [Canada] ; Philip Seeman [Canada] ; Mary V. Seeman [Canada] | Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response |
| 001007 (2013) |
K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse] | Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study |
| 001027 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Alain Destée [France] ; Nobutaka Hattori [Japon] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Werner Poewe [Autriche] ; Mark Stacy [États-Unis] ; Eduardo Tolosa [Espagne] ; Haitao Gao [États-Unis] ; Jennifer Nagel [Suisse] ; Martin Merschhemke [Suisse] ; Ana Graf [Suisse] ; Christopher Kenney [États-Unis] ; Claudia Trenkwalder [Allemagne] | AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study |
| 001280 (2012) |
Connie Marras [Canada] ; Nathan Herrmann ; Geoffrey M. Anderson ; Hadas D. Fischer ; Xuesong Wang ; Paula A. Rochon | Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex. |
| 001859 (2011) |
Richard A. Walsh [Canada] ; Anthony E. Lang [Canada] | Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine |
| 001881 (2011) |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
| 001954 (2011) |
Alexander Klein [Canada] ; Darryl C. Gidyk [Canada] ; Alexandra M. Shriner [Canada] ; Keri L. Colwell [Canada] ; Nadine A. Tatton [Canada] ; William G. Tatton [Canada] ; Gerlinde A. Metz [Canada] | Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: A cautionary note |
| 001966 (2011) |
A. Q. Rana [Canada] ; J. Depradine [Canada] | Abdominal Pain: A Symptom of Levodopa End of Dose Wearing off in Parkinson's Disease |
| 001D52 (2009) |
A L Allen [Canada] ; C. Luo ; D L Montgomery ; A H Rajput ; C A Robinson ; A. Rajput | Vascular pathology in male Lewis rats following short-term, low-dose rotenone administration. |
| 001F83 (2009) |
P J Mease [États-Unis] ; K. Hobbs [États-Unis] ; A. Chalmers [Canada] ; H. El-Gabalawy [Canada] ; A. Bookman [Canada] ; E. Keystone [Canada] ; D E Furst [États-Unis] ; P. Anklesaria [États-Unis] ; A E Heald [États-Unis] | Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study |
| 002455 (2007) |
Jackie Gour [Canada] ; Roderick Edwards ; Sarah Lemieux ; Mehrdad Ghassemi ; Mandar Jog ; Christian Duval | Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease. |
| 002D31 (2004) |
Lynsey E. Bartlett [Canada] ; Damaso Sadi [Canada] ; Matthew Lewington [Canada] ; Ivar Mendez [Canada] ; Nicholas M. Boulis ; Charles Y. Liu ; Andres M. Lozano ; Roy A. E. Bakay | Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats. Comments |
| 003A66 (1997) |
L A Tugg [Canada] ; D. Desai ; P. Prendergast ; G. Remington ; K. Reed ; R B Zipursky | Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects. |
| 003E86 (1996) |
P. J. Blanchet [Canada] ; P. Allard [Canada] ; L. Gregoire [Canada] ; F. Tardif [Canada] ; P. J. Bedard [Canada] | Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients |
| 004040 (1995) |
Wilson C. Mertens [Canada] ; Diponkar Banerjee [Canada] ; Nahla Al-Mutter [Canada] ; Larry Stitt [Canada] ; Vivien H. C. Bramwell [Canada] ; Peeyush K. Lala [Canada] | High-dose continuous venous infusion of interleukin-2: Influence of dose and infusion rate on tumoricidal function and lymphocyte subsets |
| 004296 (1994) |
B. P. Connop [Canada] ; N. G. Rolfe ; R. J. Boegman [Canada] ; K. Jhamandas [Canada] ; R. J. Beninger | Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole |
| 004955 (1990) |
Sean W. Kennedy [Canada] ; Donald C. Wigfield [Canada] | Dose-response relationships in hexachlorobenzene-induced porphyria |
| 004956 (1990) |
N. A. Seniuk [Canada] ; W. G. Tatton [Canada] ; C. E. Greenwood [Canada] | Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP |
| 004B42 (1989) |
J. K. C. Tsui ; E. C. Wolters ; R. F. Peppard ; D. B. Calne | A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "dose"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "dose" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= dose
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
